Notice of Open Meeting, 36202-36203 [2013-14172]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
36202
Federal Register / Vol. 78, No. 116 / Monday, June 17, 2013 / Notices
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cell,
Computational, and Molecular Biology.
Date: July 11, 2013.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Maria DeBernardi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7892, Bethesda, MD 20892, 301–435–
1355, debernardima@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Substance Abuse and Associated Problems of
Veterans, Military Personnel and Their
Families.
Date: July 17–18, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: John H. Newman, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222,
MSC 7808, Bethesda, MD 20892, (301) 267–
9270, newmanjh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Endocrinology and Reproduction.
Date: July 17, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Oncology.
Date: July 17, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Michael L. Bloom, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7804, Bethesda, MD 20892, 301–451–
0132, bloomm2@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflict: Drugs and Alcohol.
Date: July 17, 2013.
VerDate Mar<15>2010
20:38 Jun 14, 2013
Jkt 229001
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3134,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, mselmanoff@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Microbiology and Infectious Diseases AREA
Review.
Date: July 17–18, 2013.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Liangbiao Zheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
MSC 7808, Bethesda, MD 20892, 301–996–
5819, zhengli@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Bioengineering Sciences and Technologies:
AREA Review.
Date: July 17–18, 2013.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Joseph Thomas Peterson,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9694, petersonjt@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–11–
100: Alzheimer’s Disease Pilot Clinical
Trials.
Date: July 17, 2013.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Mark Lindner, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, 301–435–
0913, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Molecular Neurogenetics and
Neuroimaging.
Date: July 17, 2013.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Paek-Gyu Lee, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4201,
MSC 7812, Bethesda, MD 20892, (301) 613–
2064, leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Biology.
Date: July 17, 2013.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Charles Morrow, MD,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, 301–451–
4467, morrowcs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflict: Neurobiology of Member Formation,
Decision Making and Somatosensory
Processing.
Date: July 17, 2013.
Time: 3:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Wei-Qin Zhao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC 7846, Bethesda, MD 20892–7846, 301–
435–1236, zhaow@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 11, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–14204 Filed 6–14–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Open Meeting
The National Institute of
Diabetes and Digestive and Kidney
Diseases (NIDDK), a research institute of
the National Institutes of Health (NIH),
Department of Health and Human
Services (DHHS), will hold a scientific
meeting titled ‘‘Novel Phenotyping
Methods in Symptoms of Lower Urinary
Tract Dysfunction’’ and invites the
public to attend.
SUMMARY:
June 19, 2013 from 12:00 p.m.–
1:00 p.m.
DATES:
E:\FR\FM\17JNN1.SGM
17JNN1
Federal Register / Vol. 78, No. 116 / Monday, June 17, 2013 / Notices
This is a virtual meeting,
and registration information will be sent
upon request.
SUPPLEMENTARY INFORMATION: NIDDK is
seeking individuals, companies, or
organizations that have or use novel and
innovative imaging, mobile smart apps,
handheld devices, wireless and remote
technologies and new tools or devices to
evaluate/measure lower urinary
function/dysfunction. There may be
opportunities to use those technologies
in a future phenotyping cohort. This
webinar is intended to provide
information on the opportunities for
novel phenotyping methods to be tested
in prospective cohort to the potentially
interested parties. This webinar is free
and open to the public. Early
registration is requested, registration
requests after June 18, 2013 COB will
not be honored. For more information
please contact Dr. Ziya Kirkali.
FOR FURTHER INFORMATION CONTACT: Ziya
Kirkali, M.D.; Senior Scientific Advisor,
Division of Kidney, Urology and
Hematology, NIDDK, NIH. Phone: 301–
594–7717, Email: kirkaliz@mail.nih.gov.
ADDRESSES:
Dated: June 6, 2013.
Griffin P. Rodgers,
Director, National Institute of Diabetes and
Digestive and Kidney Diseases, National
Institutes of Health.
[FR Doc. 2013–14172 Filed 6–14–13; 8:45 am]
BILLING CODE 4140–01–P
Date: July 9, 2013.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Priti Mehrotra, Ph.D.,
Chief, Immunology Review Branch, Scientific
Review Program, National Institutes of
Health/NIAID, 6700B Rockledge Drive, Room
3138, Bethesda, MD 20892–7616, 301–435–
9369, pm158b@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Clinical Trials Units for
NIAID Networks.
Date: July 10, 2013.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700A
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Robert C. Unfer, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 6700–B
Rockledge Dr., MSC–7616, Bethesda, MD
20892–7616, 301–496–2550,
robert.unfer@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 11, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–14208 Filed 6–14–13; 8:45 am]
BILLING CODE 4140–01–P
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Collaborative Network for
Clinical Research on Immune Tolerance.
VerDate Mar<15>2010
20:38 Jun 14, 2013
Jkt 229001
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Diabetes and Digestive and Kidney
Diseases Special Emphasis Panel, July
01, 2013, 01:00 p.m. to July 01, 2013,
02:00 p.m., National Institutes of Health,
Two Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD, 20892 which
was published in the Federal Register
on June 06, 2013, 78 FR 34111.
The name of the meeting was changed
to Ancillary Studies on Health
Insurance Designs. The meeting is
closed to the public.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
36203
Dated: June 11, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–14210 Filed 6–14–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Pretesting of Substance Abuse
Prevention and Treatment and Mental
Health Services Communication
Messages—(OMB No. 0930–0196)—
Extension
As the Federal agency responsible for
developing and disseminating
authoritative knowledge about
substance abuse prevention, addiction
treatment, and mental health services
and for mobilizing consumer support
and increasing public understanding to
overcome the stigma attached to
addiction and mental illness, the
Substance Abuse and Mental Health
Services Administration (SAMHSA) is
responsible for development and
dissemination of a wide range of
education and information materials for
both the general public and the
professional communities. This
submission is for generic approval and
will provide for formative and
qualitative evaluation activities to (1)
assess audience knowledge, attitudes,
behavior and other characteristics for
the planning and development of
messages, communication strategies and
public information programs; and (2)
test these messages, strategies and
program components in developmental
form to assess audience comprehension,
reactions and perceptions. Information
obtained from testing can then be used
to improve materials and strategies
while revisions are still affordable and
possible. The annual burden associated
with these activities is summarized
below.
E:\FR\FM\17JNN1.SGM
17JNN1
]]>Agencies
[Federal Register Volume 78, Number 116 (Monday, June 17, 2013)]
[Notices]
[Pages 36202-36203]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-14172]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Open Meeting
SUMMARY: The National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK), a research institute of the National Institutes of
Health (NIH), Department of Health and Human Services (DHHS), will hold
a scientific meeting titled ``Novel Phenotyping Methods in Symptoms of
Lower Urinary Tract Dysfunction'' and invites the public to attend.
DATES: June 19, 2013 from 12:00 p.m.-1:00 p.m.
[[Page 36203]]
ADDRESSES: This is a virtual meeting, and registration information will
be sent upon request.
SUPPLEMENTARY INFORMATION: NIDDK is seeking individuals, companies, or
organizations that have or use novel and innovative imaging, mobile
smart apps, handheld devices, wireless and remote technologies and new
tools or devices to evaluate/measure lower urinary function/
dysfunction. There may be opportunities to use those technologies in a
future phenotyping cohort. This webinar is intended to provide
information on the opportunities for novel phenotyping methods to be
tested in prospective cohort to the potentially interested parties.
This webinar is free and open to the public. Early registration is
requested, registration requests after June 18, 2013 COB will not be
honored. For more information please contact Dr. Ziya Kirkali.
FOR FURTHER INFORMATION CONTACT: Ziya Kirkali, M.D.; Senior Scientific
Advisor, Division of Kidney, Urology and Hematology, NIDDK, NIH. Phone:
301-594-7717, Email: kirkaliz@mail.nih.gov.
Dated: June 6, 2013.
Griffin P. Rodgers,
Director, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2013-14172 Filed 6-14-13; 8:45 am]
BILLING CODE 4140-01-P
